154 related articles for article (PubMed ID: 32058933)
1. Tacrolimus treatment in childhood refractory nephrotic syndrome: A retrospective study on efficacy, therapeutic drug monitoring, and contributing factors to variable blood tacrolimus levels.
Guo HL; Xu J; Sun JY; Li L; Guo HL; Jing X; Xu ZY; Hu YH; Xu ZJ; Sun F; Ding XS; Chen F; Zhao F
Int Immunopharmacol; 2020 Apr; 81():106290. PubMed ID: 32058933
[TBL] [Abstract][Full Text] [Related]
2. Diltiazem on tacrolimus exposure and dose sparing in Chinese pediatric primary nephrotic syndrome: impact of CYP3A4, CYP3A5, ABCB1, and SLCO1B3 polymorphisms.
Wang J; Huang L; Gao P; Hu Y; Ni Y; Zhu Z; Zhang L; Yang J; Zhang H; Fang L
Eur J Clin Pharmacol; 2021 Jan; 77(1):71-77. PubMed ID: 32803289
[TBL] [Abstract][Full Text] [Related]
3. Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndrome.
Mo X; Li J; Liu Y; Liao X; Tan M; Chen Y; He F; He Y; Li Y; Huang M
Pharmacogenomics J; 2020 Aug; 20(4):543-552. PubMed ID: 31902946
[TBL] [Abstract][Full Text] [Related]
4. CYP3A5*3 polymorphism and age affect tacrolimus blood trough concentration in myasthenia gravis patients.
Fan Z; Zheng D; Wen X; Shen F; Lei L; Su S; Zhang S; Liu Q; Zhang X; Lu Y; Di L; Shen XM; Da Y
J Neuroimmunol; 2021 Jun; 355():577571. PubMed ID: 33866281
[TBL] [Abstract][Full Text] [Related]
5. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome.
Li L; Zhu M; Li DY; Guo HL; Hu YH; Xu ZY; Jing X; Chen F; Zhao F; Li YM; Xu J; Jiao Z
Int Immunopharmacol; 2021 Sep; 98():107827. PubMed ID: 34284341
[TBL] [Abstract][Full Text] [Related]
6. Impact of
Huang L; Wang J; Yang J; Zhang H; Ni Y; Zhu Z; Wang H; Gao P; Wu Y; Mao J; Fang L
Pharmacogenomics; 2019 Oct; 20(15):1071-1083. PubMed ID: 31588879
[No Abstract] [Full Text] [Related]
7. Combined Effect of Inter- and Intrapatient Variability in Tacrolimus Exposure on Graft Impairment Within a 3-Year Period Following Kidney Transplantation: A Single-Center Experience.
Stefanović NZ; Veličković-Radovanović RM; Danković KS; Mitić BP; Paunović GJ; Cvetković MB; Cvetković TP
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):749-760. PubMed ID: 32886348
[TBL] [Abstract][Full Text] [Related]
8. Dynamic effects of CYP3A5 polymorphism on dose requirement and trough concentration of tacrolimus in renal transplant recipients.
Chen P; Li J; Li J; Deng R; Fu Q; Chen J; Huang M; Chen X; Wang C
J Clin Pharm Ther; 2017 Feb; 42(1):93-97. PubMed ID: 27885697
[TBL] [Abstract][Full Text] [Related]
9. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients.
Li DY; Teng RC; Zhu HJ; Fang Y
Int J Clin Pharmacol Ther; 2013 Jun; 51(6):466-74. PubMed ID: 23557867
[TBL] [Abstract][Full Text] [Related]
10. Associations of HSD11B1 polymorphisms with tacrolimus concentrations in Chinese renal transplant recipients with prednisone combined therapy.
Liu X; Li J; Fu Q; Liu S; Zhang Y; Wang X; Wang H; Li J; Zhu C; Wang C; Huang M
Drug Metab Dispos; 2015 Apr; 43(4):455-8. PubMed ID: 25587129
[TBL] [Abstract][Full Text] [Related]
11. CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic range proteinuria.
Liu H; Xu Q; Huang W; Zhao Q; Jiang Z; Kuang X; Li Z; Sun H; Qiu X
Eur J Clin Pharmacol; 2019 Nov; 75(11):1533-1540. PubMed ID: 31401678
[TBL] [Abstract][Full Text] [Related]
12. Effect of CYP3 A4, CYP3 A5 and ABCB1 gene polymorphisms on the clinical efficacy of tacrolimus in the treatment of nephrotic syndrome.
Li M; Xu M; Liu W; Gao X
BMC Pharmacol Toxicol; 2018 Apr; 19(1):14. PubMed ID: 29615122
[TBL] [Abstract][Full Text] [Related]
13. CYP3A5 polymorphisms and their effects on tacrolimus exposure in an ethnically diverse South African renal transplant population.
Muller WK; Dandara C; Manning K; Mhandire D; Ensor J; Barday Z; Freercks R
S Afr Med J; 2020 Jan; 110(2):159-166. PubMed ID: 32657689
[TBL] [Abstract][Full Text] [Related]
14. Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelines.
Elens L; Capron A; van Schaik RH; De Meyer M; De Pauw L; Eddour DC; Latinne D; Wallemacq P; Mourad M; Haufroid V
Ther Drug Monit; 2013 Oct; 35(5):608-16. PubMed ID: 24052064
[TBL] [Abstract][Full Text] [Related]
15. Effect of CYP3A5 and ABCB1 Gene Polymorphisms on Tacrolimus Blood Concentration in Renal Transplant Recipients.
Yildirim E; Şahin G; Kaltuş Z; Çolak E
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710427
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome.
Jahan A; Prabha R; Chaturvedi S; Mathew B; Fleming D; Agarwal I
Pediatr Nephrol; 2015 Nov; 30(11):1961-7. PubMed ID: 26135137
[TBL] [Abstract][Full Text] [Related]
17. Individualized Tacrolimus Therapy for Pediatric Nephrotic Syndrome: Considerations for Ontogeny and Pharmacogenetics of CYP3A.
Sun JY; Xu ZJ; Sun F; Guo HL; Ding XS; Chen F; Xu J
Curr Pharm Des; 2018; 24(24):2765-2773. PubMed ID: 30156148
[TBL] [Abstract][Full Text] [Related]
18. Survival Time to Biopsy-Proven Acute Rejection and Tacrolimus Adverse Drug Reactions in Pediatric Liver Transplantation.
Riva N; Dip M; Halac E; Cáceres Guido P; Woillard JB; Licciardone N; Chan D; Buendía J; Borgnia D; Bosaleh A; de Davila MT; Imventarza O; Schaiquevich P
Ther Drug Monit; 2018 Aug; 40(4):401-410. PubMed ID: 29621122
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Concentration Errors and Inappropriate Dose Tailoring of Tacrolimus Caused by Sampling-Time Deviations in Pediatric Patients With Primary Nephrotic Syndrome.
Wang J; Gao P; Zhang H; Hu Y; Ni Y; Zhu Z; Zhang L; Wang H; Yang J; Ji C; Wu M; Huang L; Fang L
Ther Drug Monit; 2020 Jun; 42(3):392-399. PubMed ID: 31855975
[TBL] [Abstract][Full Text] [Related]
20. CYP3A and ABCB1 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of tacrolimus and its metabolites (M-I and M-III).
Yoon SH; Cho JH; Kwon O; Choi JY; Park SH; Kim YL; Yoon YR; Won DI; Kim CD
Transplantation; 2013 Mar; 95(6):828-34. PubMed ID: 23364483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
